NIFTY 50

Biocon Biologics in talks with ADQ to raise fresh capital

Updated : November 24, 2020 03:00 PM IST

Kiran Mazumdar-led Biocon Biologics is in the midst of a fund raising blitzkrieg in 2020. It recently sealed a deal with Wall Street powerhouse Goldman Sachs and now it’s in talks for a fourth fund raise.

According to a report by moneycontrol.com, post the Goldman Sachs deal, Biocon Biologics is now in talks with ADQ for a fresh shot of funds.

ADQ is a sovereign wealth fund owned by Abu Dhabi government. ADQ is looking to invest up to 100 million dollars in Biocon Biologics and due diligence is underway.

Watch this video for more.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you